Jan 8 (Reuters) -

* ESSENTIAL PHARMA ACQUIRES EUROPEAN RIGHTS TO COLOBREATHE®(COLISTIMETHATE SODIUM) FROM TEVA Source text link: https://refini.tv/3NTbLHg